Tango Therapeutics, Inc. (TNGX)

NGM – Real Time Price. Currency in USD

25.58

-0.76 (-2.89%)

At close: Aug 12, 2026, 4:00 PM EDT

25.58

0.00 (0.00%)

After-hours: Aug 12, 2026, 4:15 PM EDT

12.08.2026

TNGX Stock Dips 5% as Q2 Earnings Miss Estimates on Higher Expenses

Tango Therapeutics stock falls 5% on a wider-than-expected Q2 loss, reflecting higher operating expenses, while pipeline progress remains in focus.

06.08.2026

Tango Therapeutics Announces Executive Chair Transition

BOSTON, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that Dr. Barbara Weber, the Executive Chairman of the Board of Directors of Tango Therapeutics, will be stepping down in connection with other pursuits.

03.08.2026

4 Biotech Stocks Likely to Outpace Q2 Earnings Estimates

Medical sector earnings are off to a strong start, and four biotech companies are positioned to potentially beat estimates in upcoming quarterly results.

Videos

No Data

There is no data to display

Press releases

06.08.2026

Tango Therapeutics, Inc. (TNGX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Tango Therapeutics, Inc. (TNGX)

TNGX Stock Dips 5% as Q2 Earnings Miss Estimates on Higher Expenses

Tango Therapeutics Announces Executive Chair Transition

4 Biotech Stocks Likely to Outpace Q2 Earnings Estimates

Videos

No Data

Press releases

Tango Therapeutics Announces Executive Chair Transition

TNGX Stock Dips 5% as Q2 Earnings Miss Estimates on Higher Expenses

Tango Therapeutics Announces Executive Chair Transition

4 Biotech Stocks Likely to Outpace Q2 Earnings Estimates

Videos

No Data

Press releases

Tango Therapeutics Announces Executive Chair Transition

Search stocks

Tango Therapeutics, Inc. (TNGX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Tango Therapeutics, Inc. (TNGX)

TNGX Stock Dips 5% as Q2 Earnings Miss Estimates on Higher Expenses

Tango Therapeutics Announces Executive Chair Transition

4 Biotech Stocks Likely to Outpace Q2 Earnings Estimates

Videos

No Data

Press releases

Tango Therapeutics Announces Executive Chair Transition

TNGX Stock Dips 5% as Q2 Earnings Miss Estimates on Higher Expenses

Tango Therapeutics Announces Executive Chair Transition

4 Biotech Stocks Likely to Outpace Q2 Earnings Estimates

Videos

No Data

Press releases

Tango Therapeutics Announces Executive Chair Transition